ImmuneOncia Therapeutics, Inc.

₩2,380As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:424870Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (39.66%)
Pharmaceutical Preparations
Beta (5Y) —
PE TTM —
TSR TTM (56.12%)
Mkt cap ₩217.5B
ROIC (25.51%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,852
19.82%
215.16%
Hold 10|2|1|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
32.06
35.35
36.86
36.60
0.88%
9.68%
14.68%
15.96%
Revenue₩B
10.40
11.01
11.55
11.54
(1.32%)
5.82%
14.03%
15.96%
Peers (US$160.4M)
Cap (US$)
PE
120.1M
—
Capital
TTM
5Y
10Y
Leveragex
10.47
(0.126)
(0.111)
EBIT/Intx
0.676
0.139
0.134
Own earn%
67.59
(146.49)
(128.53)
Sh yield%
40.12
35.52
31.38
Owners
Insiders/Inst%
9.06
37.48
Short interest%
3.24
SBC / revenue%
4.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
0–10
$1 testx
0.0
Incr. ROIC%
7